University of Missouri School of Medicine MU Health School of Medicine
News Divider
            


Stefan Sarafianos, PhD
Stefan Sarafianos, PhD, assistant professor of microbiology and immunology at the MU School of Medicine, has identified a new mutation that allows HIV to elude treatment. His research recently appeared in the Journal of Biological Chemistry and Nature Structural & Molecular Biology.


New Discoveries Make it Harder for HIV to Hide from Drugs


How the virus can escape even the best cocktail of treatments described in Nature journal

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells change as they reproduce is key to developing better tests and treatments for patients.

In the Journal of Biological Chemistry and Nature Structural & Molecular Biology, MU microbiologist and biochemist Stefan Sarafianos, PhD, reveals new findings that shed light on how HIV eludes treatment by mutating. His discoveries provide clues into HIV's mechanisms for resisting two main families of drugs.

"These findings are important because identifying a new mutation that affects HIV drug resistance allows physicians to make better decisions and prescribe the proper drugs," Sarafianos said. "Without that knowledge, therapy can be suboptimal and lead to early failure."

Patients with HIV are routinely tested to track the levels of the virus and immune cells in their body. Results of the tests help physicians gauge the health of their patients and prescribe the right mix of antiviral drugs. The drugs help prevent the spread of HIV in patients by inhibiting the virus' ability to replicate.

Sarafianos' lab determined the biochemical properties that allow strains of HIV with a specific mutation — the N348I mutation — to escape inhibition despite treatment with Nevirapine. The drug is commonly used in combination with other antiviral medications to decrease the amount of HIV in the blood. As a result of Sarafianos' discovery, at least one major company that manufactures HIV mutation-testing kits has modified its test to detect the N348I mutation.

Sarafianos' recent findings resulted from research supported by five National Institutes of Health grants. He recently received another $417,000 award from the NIH to assist him in developing modified antibodies for HIV therapy.

"Our latest efforts to design broadly neutralizing antibodies against HIV will hopefully expand our toolbox against the virus, which remains a constantly moving target," Sarafianos said.



MU Health Magazine

Divider

News and Events

White Coat Ceremony 2015 White Coat Ceremony Marks Start of Professional Journey for 104 Students
Students receive 'cloak of compassion' and pledge to uphold medicine's highest values

Eduardo Simoes, MD Tool Helps Public Health Agencies Prioritize Health Risks
Researcher works with Brazil to identify top risks for chronic diseases

Washington and Khosla U.S. South Asians More Reluctant to Seek Medication for Pain
Health care workers should be culturally aware when caring for patients, families

Segal Blood Vessels Can Actually Get Better With Age
Study finds that arteries adapt to oxidative stress caused by aging

Koopman Professor Awarded $2.2 Million Grant for Clear Blood Pressure Display
Goal is user-friendly information for better patient understanding

Scallan Impact of Type 2 Diabetes on Lymphatic Vessels Identified
Amino acid found in red meat, poultry may improve lymphatic function in diabetes

Springfield MU, CoxHealth, Mercy Address Critical Shortage of Physicians
Construction starts on new $42.5 million Patient-Centered Care Learning Center

Parrish Age-related self-destruction of cells makes kidney prone to injury
Researchers identify how the kidney cells’ self-destruct messages are spread

Staveley-O'Carroll Staveley-O’Carroll Named Surgery Chair, Cancer Center Director
Staveley-O’Carroll is accomplished physician-scientist

Mini Med High School Students get Hands-On Medical School Experience
MU School of Medicine hosts High School Mini Medical School

Cristo Rey MU Health System Partnership Promotes Diversity
Annual summit encourages students to try on health care careers

Hwang Key Component in Protein that Causes Cystic Fibrosis Identified
Findings may lay foundation for the development of medications

SOM Graduation 2015 MU School of Medicine to Award 101 Medical Degrees at Commencement
Forty-five will remain in Missouri for specialty training in residency




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323

Diamond Dixon
DixonDi@health.missouri.edu
(573) 884-7541

Justin Kelley (Photographer)
kelleyju@health.missouri.edu
(573) 882-5786
Pager (573) 397-9289


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Rich Gleba
glebar@health.missouri.edu
(573) 884-0298

Laura Gerding, APR
gerdingla@health.missouri.edu
(573) 882-9193

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.